Aseptuva Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A
- (In Progress)
- Latest Deal Amount
-
$6.18M
- Investors
-
13
Aseptuva General Information
Description
Developer of in-situ disinfection technology designed to prevent pathogenic colonization in and around different catheters. The company's technology supports medical staff with a robust automated system, reducing additional healthcare costs by preventing hospital-acquired infections, enabling hospitals to eliminate the risk of infections and save lives every year.
Contact Information
Website
www.aseptuva.comCorporate Office
- Weyermannsstrasse 36
- 3008 Bern
- Switzerland
Corporate Office
- Weyermannsstrasse 36
- 3008 Bern
- Switzerland
Aseptuva Timeline
Aseptuva Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series A) | 18-Sep-2026 | $6.18M | In Progress | Generating Revenue | ||
| 11. Seed Round | 18-Sep-2026 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Accelerator/Incubator | 01-Nov-2024 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 10-Sep-2024 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 24-May-2024 | Completed | Generating Revenue | |||
| 6. Grant | 01-Jun-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Oct-2022 | $87.4K | $610K | Completed | Generating Revenue | |
| 3. Seed Round | 30-Aug-2022 | $523K | $523K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aseptuva Patents
Aseptuva Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025202491-A1 | Device for guiding a tubular element in a vicinity of a point of entry into a human or animal body and for disinfecting tissue surrounding the point of entry | Pending | 28-Mar-2024 | ||
| EP-4346917-A1 | System for disinfecting skin tissue around catheters | Active | 28-May-2021 | ||
| EP-4346917-B1 | System for disinfecting skin tissue around catheters | Active | 28-May-2021 | ||
| EP-4346917-C0 | System for disinfecting skin tissue around catheters | Active | 28-May-2021 | ||
| US-20250009468-A1 | System for disinfecting skin tissue around catheters | Pending | 28-May-2021 | A61L2/10 |
Aseptuva Signals
Aseptuva Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Auxinam | Family Office | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| WeInvest Capital Partners | Asset Manager | Minority |
Aseptuva FAQs
-
When was Aseptuva founded?
Aseptuva was founded in 2020.
-
Where is Aseptuva headquartered?
Aseptuva is headquartered in Bern, Switzerland.
-
What is the size of Aseptuva?
Aseptuva has 8 total employees.
-
What industry is Aseptuva in?
Aseptuva’s primary industry is Medical Supplies.
-
Is Aseptuva a private or public company?
Aseptuva is a Private company.
-
What is Aseptuva’s current revenue?
The current revenue for Aseptuva is .
-
How much funding has Aseptuva raised over time?
Aseptuva has raised $4.1M.
-
Who are Aseptuva’s investors?
, Auxinam, , , and WeInvest Capital Partners are 5 of 13 investors who have invested in Aseptuva.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process